Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Atherosclerosis. 2014 Dec 20;239(1):50–54. doi: 10.1016/j.atherosclerosis.2014.12.005

Table 1.

Characteristics of Participants (n=150) from the Hawaii Aging with HIV - Cardiovascular Study Cohort

Characteristic % or mean ± STD/median [IQR]where indicated

Age, mean (yrs) 52

Female (%) 12

Tobacco-past (%) 66

Tobacco-current (%) 25

Viral load undetectable (< 48 copies/mm3) (%) 85

CD4 count, cell/mm3 524

Nadir CD4 count, cell/mm3 167

HAART (%) 100
 NRTI* 96
 NNRTI* 51
 PI* 47

Ethnicity (%)
 White 58
 African American/Black 4
 Native American/Native Alaskan 2
 Pacific Islander 1
 Asian 8
 More than one race 24
 Unknown 3

Hypertension (%)
 Total 67
  On medications 76 (among total hypertensives)
  Diet controlled 54 (among total hypertensives)

On lipid lowering medication 31

Diabetes (%) 7

HOMA-IR, mean ± STD 2.53 ± 3.77

Body Mass Index, kg/m2, mean ± STD 26.5 ± 4.6

Systolic blood pressure, mmHg, mean ± STD 123 ± 16

Diastolic blood pressure, mmHg, mean ± STD 76 ± 10

Total cholesterol, mg/dL, mean ± STD 179.9 ± 40.3

HDL cholesterol, mg/dL, mean ± STD 44.5 ± 17.4

LDL cholesterol, mg/dL, mean ± STD 110 ± 35

Triglycerides, mg/dL: median[IQR] 117.5[87–168[

STD=Standard deviation

IQR=interquartile range

HOMA-IR- homeostasis model assessment of insulin resistance

NRTI=nucleoside/nucleotide reverse transcriptase inhibitor, NNRTI= non-nucleoside/nucleotide reverse transcriptase inhibitor, PI=protease inhibitor

*

not mutually exclusive, participants could be on more than one class